StonvexLoading…
StonvexStonvexStonvexCore line items from ANIK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $29.61M | $112.82M | $82.20M | $54.39M |
Operating Income | $-5.49M | $-11.05M | $-11.70M | $-8.46M |
Net Income | $-5.06M | $-10.88M | $-11.17M | $-3.97M |
EPS (Diluted) | $-0.37 | $-0.76 | $-0.78 | $-0.62 |
Total Assets | $179.39M | $190.27M | $189.44M | $187.68M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $41.02M | $57.48M | $57.99M | $53.17M |
Free Cash Flow OCF − CapEx | $-6.28M | $4.36M | $373.00K | $-4.61M |
Shares Outstanding | 13.36M | 13.89M | 14.42M | 14.42M |